West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
Go back to West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation| (NASDAQ: ICCM) | Delayed: 2.23 +0.03 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.20 | 52 Week High | $ | |||
| Open | $2.20 | 52 Week Low | $ | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 58,440 | |||||

